Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Bristol-Myers Squibb Discovered Abecma First CAR T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb has discovered Abecma® as a CAR T therapy for treating patients with relapsed or refractory multiple myeloma in Japan....
Osteal Therapeutics Developed Novel VT-X7 Therapy for the Treatment of Periprosthetic Joint Infection
Osteal Therapeutics has developed an innovative drug therapy, VT-X7, specifically designed to address periprosthetic joint infection affecting the hip and knee....
Johnson & Johnson Introduces Breakthrough TAR-200 Therapy for Non-Muscle-Invasive Bladder Cancer
Johnson & Johnson has unveiled TAR-200 therapy, aimed at potentially treating individuals diagnosed with high-risk non-muscle-invasive bladder cancer that doesn't respond to Bacillus Calmette-Guérin treatment....
Neurocrine Biosciences Introduces Novel Crinecerfont for Congenital Adrenal Hyperplasia
Neurocrine Biosciences has introduced crinecerfont as a novel treatment for congenital adrenal hyperplasia (CAH)....
Haseltine Lake Kempner Discovered World’s First CASGEVY™ for the Treatment of Sickle Cell Disease
HLK's discovered CASGEVY™ as the world's first approved CRISPR/Cas9 gene-editing therapy for treating both sickle cell disease (SCD) and transfusion-dependant beta thalassaemia (TDT)....
AbbVie Introduced First-of-kind Epcoritamab for the Treatment of Relapsed/Refractory Follicular Lymphoma
AbbVie has introduced Epcoritamab (epkinly®/tepkinly®) for the treatment of relapsed/refractory follicular lymphoma....
SpringWorks Therapeutics Developed Novel OGSIVEO™ for the Treatment of Desmoid Tumours
SpringWorks Therapeutics has developed OGSIVEO™ (nirogacestat) as the first and only treatment for adults with desmoid tumours....
Celltrion Developed First-of-its-kind ZYMFENTRA™ for Inflammatory Bowel Disease Treatment
Celltrion discovered ZYMFENTRA™ (infliximab-dyyb), the first and only subcutaneous infliximab treatment, designed specifically for individuals suffering from inflammatory bowel disease. ...
Vertex Pharmaceuticals and CRISPR Therapeutics Unveil Breakthrough CASGEVY™ Gene-Edited Therapy for Sickle Cell Disease
Vertex Pharmaceuticals and CRISPR Therapeutics have collaborated to develop a groundbreaking gene-edited therapy known as CASGEVY™ specifically designed to address sickle cell disease...
Imperial College London Introduces Casgevy New Therapy for the Blood Disorder Treatment
Imperial College London has recently unveiled an innovative gene therapy known as Casgevy, offering promising prospects as a potential treatment for two inherited blood disorders....
